Horizon Space II Extends Merger Deadline with SL Bio, Discloses High Redemptions

summarizeSummary

Horizon Space Acquisition II Corp. extended its business combination deadline with SL Bio by one month to March 18, 2026, funded by a $50,000 promissory note from SL Bio's CEO, while also disclosing significant share redemptions.

check_boxKey Events

• Merger Deadline Extended

  The company extended its deadline to complete the business combination with SL Bio by one month, from February 18, 2026, to March 18, 2026. This is the first of twelve possible one-month extensions.

• Promissory Note Issued

  SL Bio's CEO, William Wang, deposited $50,000 into the trust account to fund the extension. In return, Horizon Space Acquisition II Corp. issued an unsecured, non-interest-bearing promissory note of $50,000 to Mr. Wang, convertible into private units at $10.00 per unit upon the business combination.

• Shareholder Approvals Confirmed

  Shareholders approved the business combination proposals, amended M&A proposal, and sole director appointment proposal on February 12, 2026. They also approved the MAA Amendment Proposal and Trust Amendment Proposal on February 13, 2026.

• Significant Share Redemptions

  The company reported 2,012,378 public shares redeemed in connection with the business combination and an additional 4,709,337 public shares redeemed for the extension, totaling 6,721,715 shares.

auto_awesomeAnalysis

This filing provides crucial updates on Horizon Space Acquisition II Corp.'s path to completing its business combination with SL Bio. The one-month extension, funded by a promissory note from SL Bio's CEO, signals continued commitment to the merger and provides additional time to finalize the transaction. However, the disclosure of substantial share redemptions (over 6.7 million shares) indicates a significant reduction in the public float, which is a common challenge for SPACs and could impact the liquidity and trading dynamics of the combined entity post-merger. Investors should monitor the progress towards the March 18, 2026 deadline and the final terms of the business combination.